Penumbra Inc (PEN)
$262.28 -10.96 (-4.01%)| Market Cap | 10.68B |
| Revenue (ttm) | 1.19B |
| Net Income (ttm) | 14.01M |
| EPS (ttm) | N/A |
| PE Ratio | 94.47 |
| Forward PE | 74.45 |
| Profit Margin | 1.17% |
| Debt to Equity Ratio | 0.00 |
| Volume | 576,800 |
| Avg Vol | 474,954 |
| Day's Range | N/A - N/A |
| Shares Out | 38.52M |
| Stochastic %K | 41% |
| Beta | 0.56 |
| Analysts | Strong Sell |
| Price Target | $308.06 |
Latest News on PEN
Apr 3, 2025, 4:30 PM EDT - 2 days ago
Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025
Feb 21, 2025, 4:05 PM EST - 6 weeks ago
Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors
Feb 19, 2025, 4:03 PM EST - 6 weeks ago
Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook
Feb 18, 2025, 4:05 PM EST - 6 weeks ago
Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Jan 21, 2025, 4:30 PM EST - 2 months ago
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025
Dec 30, 2024, 4:30 PM EST - 3 months ago
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 17, 2024, 11:03 AM EST - 3 months ago
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
Nov 20, 2024, 4:30 PM EST - 4 months ago
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
Oct 30, 2024, 4:05 PM EDT - 5 months ago
Penumbra, Inc. Reports Third Quarter 2024 Financial Results
Oct 14, 2024, 9:00 AM EDT - 6 months ago
Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
Oct 2, 2024, 4:30 PM EDT - 6 months ago
Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024
Sep 16, 2024, 3:00 AM EDT - 7 months ago
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe
Aug 27, 2024, 4:30 PM EDT - 7 months ago
Penumbra, Inc. to Present at the Baird Global Healthcare Conference
Aug 21, 2024, 4:30 PM EDT - 8 months ago
Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference
Aug 19, 2024, 9:28 PM EDT - 8 months ago
Penumbra: Growth In Its Thrombectomy Portfolio Should Lead To Strong Earnings
Aug 13, 2024, 7:00 AM EDT - 8 months ago
Penumbra, Inc. Announces $200 Million Share Repurchase Authorization
Aug 2, 2024, 4:30 PM EDT - 8 months ago
Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference
Jul 30, 2024, 4:05 PM EDT - 8 months ago
Penumbra, Inc. Reports Second Quarter 2024 Financial Results
Jul 2, 2024, 4:05 PM EDT - 9 months ago
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
Jun 4, 2024, 4:30 PM EDT - 10 months ago
Penumbra, Inc. to Present at the Truist Securities MedTech Conference
May 23, 2024, 4:30 PM EDT - 11 months ago
Penumbra, Inc. to Present at the William Blair Growth Stock Conference
May 7, 2024, 4:05 PM EDT - 11 months ago
Penumbra, Inc. Reports First Quarter 2024 Financial Results
May 1, 2024, 4:05 PM EDT - 1 year ago
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
Apr 23, 2024, 9:00 AM EDT - 1 year ago
Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots
Apr 9, 2024, 4:05 PM EDT - 1 year ago
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
Feb 22, 2024, 4:05 PM EST - 1 year ago
Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 1, 2024, 4:05 PM EST - 1 year ago
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024
Dec 18, 2023, 7:50 PM EST - 1 year ago
Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference
Nov 14, 2023, 4:05 PM EST - 1 year ago
Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
Nov 10, 2023, 5:43 PM EST - 1 year ago
Penumbra Teams Up with Honor Everywhere to Bring US War Memorials to Aging Veterans
Nov 1, 2023, 4:05 PM EDT - 1 year ago
NEW LATE BREAKING DATA DEMONSTRATE PENUMBRA'S COMPUTER ASSISTED VACUUM THROMBECTOMY TECHNOLOGY FOR PULMONARY EMBOLISM IMPROVED PATIENT OUTCOMES
Oct 5, 2023, 4:05 PM EDT - 1 year ago
Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023
